FDA Oversight Under Fire Following Infant Formula Botulism Outbreaks
Steady: 0 in the last 7 days
Updated sep 24
The latest in this situation
How it started
AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Two infant formula botulism outbreaks occurred, resulting in dozens of babies becoming seriously ill. During the crisis, the FDA was conducting a safety study but publicly declared the nation’s baby formula supply safe despite excluding the botulism pathogens from its testing. This disconnect between the agency's findings and its public statements led to immediate and widespread public outrage.
From wjla.com
Why it matters
The botulism outbreak has placed the issue of agency oversight squarely in the legislative agenda. Rosa DeLauro introduced legislation in Congress specifically targeting the failures within the FDA's operational scope.
From wjla.com
Who's involved
- FDARegulatory agency under scrutiny regarding product safety and oversight.
- Rosa DeLauroU.S. Representative who introduced legislation targeting FDA failures.
- CongressLegislative body responsible for overseeing the FDA's mandates.
How it developed
Newest first. Tap a step to see who reported it.- FDA rule changes are causing delays in product approval, leading to the process exceeding Congressional mandated timeframes.Sub-event
Rosa DeLauro introduced legislation in Congress targeting FDA oversight failures.1 source
Keep exploring
The entities involved
- FDA
-
Rosa DeLauro
U.S. Representative from Connecticut
-
Congress
US record label; imprint of Congress Record Corp.
Related events
- Congress and the Senate are considering legislation affecting FDA submissions and drug patent rights.
- Litigation regarding FDA approval process.
- Lawsuits filed in Seattle involve FDA oversight, while the FDA investigates food safety issues in New Jersey.
- AMA urges FDA to maintain standards as federal government implements marijuana rescheduling order amid GAO findings of regulatory deficiencies.
- Allegations surfaced that FDA officials, including a safety data-mining expert, were involved in oversight failures regarding vaccine safety signals related to Moderna.